KATP Channel Expression Determines ONC212 Sensitivity via Mitochondrial Dysfunction and PERK / ATF4 / CHOP Activation in Glioblastoma
Journal of Cellular and Molecular Medicine · 2026
DOI: 10.1111/jcmm.71301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Ahmet Taskesen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Faculty of Medicine, Düzce University, Düzce, Turkey. Hauptthemen laut MEDLINE: Mitochondria, Glioblastoma, Activating Transcription Factor 4, eIF-2 Kinase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glioblastoma (GBM) exhibits profound metabolic plasticity and resistance to conventional therapies, partly driven by mitochondrial adaptability and stress response mechanisms. ONC212, a second‐generation imipridone, targets mitochondrial proteostasis, yet determinants of tumour sensitivity remain unclear. This study aimed to investigate whether ATP‐sensitive potassium (KATP) channel expression modulates ONC212‐induced mitochondrial dysfunction and integrated stress response (ISR) activation in GBM. Human GBM lines (U87, U251, T98G) and non‐malignant SVG p12 astrocytes received ONC212 (0.5–80 μM) for 12–48 h. Viability was assessed by CCK‐8. KATP subunit expression (Kir6.2, SUR1, CCDC51) was quantified by qRT‐PCR and western blot. Mitochondrial ROS quantification, oxygen consumption rate (Seahorse XF), PERK/ATF4/CHOP activation (western blot, immunofluorescence) and apoptosis (caspase‐3/7) were evaluated. KATP was modulated pharmacologically (glibenclamide, diazoxide) and via KCNJ11 (Kir6.2) siRNA. ONC212 induced time‐dependent and tumour‐selective cytotoxicity, with highest sensitivity observed in KATP‐high U87 cells. Treatment significantly increased mitochondrial ROS, impaired oxidative phosphorylation and reduced ATP/ADP ratios, indicating bioenergetic collapse. Concurrently, ONC212 robustly activated the PERK/eIF2α/ATF4/CHOP axis and promoted ATF4 nuclear translocation. PERK inhibition attenuated both stress signalling and cytotoxicity, confirming ISR dependency. KATP inhibition enhanced ONC212‐induced mitochondrial dysfunction, ISR activation and apoptosis, whereas KATP activation exerted protective effects. Importantly, KCNJ11 silencing markedly potentiated ONC212 sensitivity, amplifying ROS production, mitochondrial impairment and caspase‐dependent apoptosis. KATP channel expression may regulate ONC212 responsiveness in GBM by modulating mitochondrial stress and ISR signalling. Targeting KATP channels may enhance imipridone efficacy and represents a promising strategy for metabolically guided GBM therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Faculty of Medicine, Düzce University, Düzce, Turkey.
- Department of Medical Biochemistry, Faculty of Medicine, Düzce University, Düzce, Turkey.
ORCID-Profile: Ahmet Taskesen, Ceyhan Hacioglu
Zitieren
APA
Taskesen, A., & Hacioglu, C. (2026). KATP Channel Expression Determines ONC212 Sensitivity via Mitochondrial Dysfunction and PERK / ATF4 / CHOP Activation in Glioblastoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71301
Vancouver
Taskesen A, Hacioglu C. KATP Channel Expression Determines ONC212 Sensitivity via Mitochondrial Dysfunction and PERK / ATF4 / CHOP Activation in Glioblastoma. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71301
BibTeX
@article{Taskesen2026,
author = {Taskesen, Ahmet and Hacioglu, Ceyhan},
title = {KATP Channel Expression Determines ONC212 Sensitivity via Mitochondrial Dysfunction and PERK / ATF4 / CHOP Activation in Glioblastoma},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
doi = {10.1111/jcmm.71301}
}
EUVIMED